OBSERVE-5 interim analysis: an observational postmarketing safety registry of etanercept for the treatment of psoriasis.
Kimball, Alexa B, David Pariser, Paul S Yamauchi, Alan Menter, Craig F Teller, Yifei Shi, Mellissa Yong, et al. 2013. “OBSERVE-5 Interim Analysis: An Observational Postmarketing Safety Registry of Etanercept for the Treatment of Psoriasis.”. Journal of the American Academy of Dermatology 68 (5): 756-64.